Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | CCR3 | P51677 | 4/20 | 0.43 |
| ▸ | NAMPT | P43490 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25735157 | 1.00 | PKM (0.44) | PKMCCR3NAMPTPOLBRAB9A | |
| SCHEMBL25735179 | 0.92 | PKM (0.46) | PKMCCR3NAMPTPOLBRAB9A | |
| SCHEMBL25735206 | 0.92 | PKM (0.46) | PKMCCR3NAMPTPOLBRAB9A | |
| SCHEMBL25735190 | 0.89 | NAMPT (0.46) | PKMCCR3NAMPTPOLBRAB9A | |
| SCHEMBL25735151 | 0.89 | NAMPT (0.46) | PKMCCR3NAMPTPOLBRAB9A | |
| SCHEMBL25735218 | 0.89 | NAMPT (0.46) | PKMCCR3NAMPTPOLBRAB9A | |
| SCHEMBL25642240 | 0.88 | PKM (0.40) | PKMCCR3NAMPTPOLBRAB9A | |
| SCHEMBL25735199 | 0.87 | NAMPT (0.48) | CCR3NAMPTCYP3A4 | |
| SCHEMBL25735265 | 0.87 | NAMPT (0.48) | CCR3NAMPTCYP3A4 | |
| SCHEMBL25735155 | 0.87 | NAMPT (0.48) | CCR3NAMPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192651-A1 | Pyrrolidine Derivative and Use Thereof | WANG, ZHEMING (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20230192651-A1 | Pyrrolidine Derivative and Use Thereof | WANG, ZHEMING (CN) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192651-A1 | Pyrrolidine Derivative and Use Thereof | NAMPT, NAPRT, NNMT | PKM 221/4885CCR3 3581/4885NAMPT 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.